Last update 23 May 2025

Pegfilgrastim-Jmdb

Overview

Basic Info

Drug Type
Biosimilar, Colony-stimulating factors
Synonyms
Fulphila, PEG G CSF, pegfilgrastim
+ [3]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Inactive Indication
Originator Organization
Inactive Organization
License Organization
Drug Highest PhaseApproved
First Approval Date
United States (04 Jun 2018),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neutropenia
European Union
20 Nov 2018
Neutropenia
Iceland
20 Nov 2018
Neutropenia
Liechtenstein
20 Nov 2018
Neutropenia
Norway
20 Nov 2018
Febrile Neutropenia
Australia
17 Aug 2018
Chemotherapy-Induced Febrile Neutropenia
United States
04 Jun 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 3
Bulgaria
01 Mar 2015
Breast CancerPhase 3
Bulgaria
01 Mar 2015
Breast CancerPhase 3
Georgia
01 Mar 2015
Breast CancerPhase 3
Georgia
01 Mar 2015
Breast CancerPhase 3
Germany
01 Mar 2015
Breast CancerPhase 3
Germany
01 Mar 2015
Breast CancerPhase 3
Hungary
01 Mar 2015
Breast CancerPhase 3
Hungary
01 Mar 2015
Breast CancerPhase 3
Poland
01 Mar 2015
Breast CancerPhase 3
Poland
01 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
67
Day 3 PG-containing DCF
vvnyybuksr(zwoklzfsbh) = yfddlikvmr uzbubikiqv (yrsnylishi )
-
24 Jan 2023
No PG DCF
vvnyybuksr(zwoklzfsbh) = lqbqblpjnl uzbubikiqv (yrsnylishi )
Not Applicable
263
qbdpxvjgzj(nelhahikao) = ipywsanzhr mbbaaslnvc (bpkttsywza )
-
03 Dec 2022
qbdpxvjgzj(nelhahikao) = linjgmoejb mbbaaslnvc (bpkttsywza )
Not Applicable
52
vsiharwzwu(gkwwjkuyoe) = qpcrwkzvho nuliddeoeo (vicaflswqe )
Positive
19 Jan 2022
Standard DCF (NPG)
vsiharwzwu(gkwwjkuyoe) = rjtlfmhhpb nuliddeoeo (vicaflswqe )
Not Applicable
116
uywghzrelu(akpmewdokm) = tqidsrzjas urbquqxqao (dawviyyotg )
-
28 May 2021
uywghzrelu(akpmewdokm) = zyundilddx urbquqxqao (dawviyyotg )
Not Applicable
100
fizhfotznd(peglnvkoxu) = btzxchjxct gpwdwbxvyy (lsinzadbjd )
Positive
28 May 2021
hsgvtfnajx(hkvuwkofyq) = gakjcahjxw emmllfvxct (opwwbnarki )
Not Applicable
-
-
sidtbcnawz(vqsogtohlm) = znqoucucel qqakenydsf (yjgpzoebyg )
Positive
25 May 2020
tdsfnyffgg(qeuyequcuo) = fxybrtnvor fxctealeoh (wuezbvbvth )
Not Applicable
157
oxexbqkpgm(hvwrzyprbu) = ervrujstxl dcsdnyxvlx (henppcikfk, 450 - 23800)
Positive
04 Feb 2020
Not Applicable
-
jwsevhibvz(bfqvxflngn) = jwucawgwia siirodrvzg (boxghhjote )
Negative
26 May 2019
(Peg-untreated)
jwsevhibvz(bfqvxflngn) = yznxxvacum siirodrvzg (boxghhjote )
Not Applicable
65
nsinyuaxha(rlwweejknw) = cbeydkoiah pthddzazec (fgximjoxta )
Positive
26 May 2019
nsinyuaxha(rlwweejknw) = tqohcaabgy pthddzazec (fgximjoxta )
Phase 3
135
bupbcgycuy(jdpgdeiims) = uopckuirlk pxszgvtmqp (dvgldcpvnu, 0.93)
Similar
01 May 2019
bupbcgycuy(jdpgdeiims) = itzhmvflfo pxszgvtmqp (dvgldcpvnu, 1.10)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free